Form 4: Carlyle Group Sells Shares of QuidelOrtho Corp (QDEL) Under 10b5-1 Trading Plan

Carlyle Group Inc. reports the sale of QuidelOrtho Corp shares across multiple transactions on July 24 and 25, 2024, executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Carlyle Group Inc. and related entities have reported the sale of QuidelOrtho Corp (QDEL) common stock.
• The sales occurred on July 24 and 25, 2024.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• A total of 619,541 shares were sold across the two days.
• The shares were sold at weighted average prices ranging from $37.9042 to $39.3148 on July 24 and $38.4043 to $39.1587 on July 25.
• Following the reported transactions, Carlyle Partners VI Cayman Holdings, L.P. beneficially owns 9,706,231 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports share sales under a pre-existing trading plan, without expressing any positive or negative views on the company's prospects.

Future Outlook

The document does not contain any specific forward-looking statements regarding QuidelOrtho Corp's future performance.

Industry Context

This Form 4 filing indicates activity by a major shareholder, Carlyle Group, in QuidelOrtho Corp. Monitoring such filings provides insights into the investment strategies and sentiment of large institutional holders, which can influence market perception of the company.

Stakeholder Impact

• The share sales by Carlyle Group could potentially exert downward pressure on QuidelOrtho Corp's stock price in the short term.
• However, the existence of a pre-arranged trading plan may mitigate concerns about the reasons for the sale.

Key Dates